Clinical Trial

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Study acronym: IMI-CART
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 12, 2024 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06498310
Lead Sponsor University Hospital, Strasbourg, France
Conditions Invasive Fungal Infections
Enrollment 100 participants
Start Date 2023-11-08
Primary Completion 2025-11 (estimated)
Study Completion 2025-11-08 (estimated)
Updated on ClinicalTrials.gov 2024-07-12